Second Primary Cancers Among Females with a First Primary Breast Cancer: a Population-based Study in Northern Portugal
Overview
Authors
Affiliations
Purpose: To estimate the incidence rate of second primary cancers (SPCs) and the cumulative incidence of metachronous [diagnosed > 2 months after a first primary cancer (FPC)] SPCs in patients with a breast FPC, and to compare the incidence of SPC [overall, synchronous (≤ 2 months of the FPC) and metachronous] with that expected in the general female population.
Methods: A cohort of patients with a breast FPC from the North Region Cancer Registry of Portugal, diagnosed in 2000-2010 (n = 15,981), was followed to 31 December 2015 for synchronous and metachronous SPCs. Cumulative incidence of metachronous SPCs considering death as a competing event, and incidence rates and standardized incidence ratios of SPCs were estimated.
Results: The diagnosis of an SPC occurred in 1229 (7.7%) of patients with a breast FPC. SPCs occurred mainly in the breast, followed by digestive organs, lung, thyroid, and female genital organs. Globally, patients with a breast FPC had a higher incidence for all types of cancer compared to the general female population, and in particular for cancers of the breast, stomach, colon, lung, lymphoma, uterus, and ovary. The 10-year cumulative incidence of metachronous SPCs following a breast FPC was 6.6% and the corresponding 10-year cumulative mortality was 26.2%.
Conclusion: In Portugal, patients with a breast FPC have a higher incidence of cancer compared to the general female population, highlighting important aspects of care, surveillance, and counselling among this growing number of patients.
Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue.
Liang X, Qin Y, Li P, Mo Y, Chen D Ther Adv Med Oncol. 2025; 17:17588359251321904.
PMID: 40012707 PMC: 11863263. DOI: 10.1177/17588359251321904.
Causal effect between breast cancer and ovarian cancer: a two-sample mendelian randomization study.
Qian C, Xing Y, Cheng W BMC Cancer. 2024; 24(1):1433.
PMID: 39573997 PMC: 11580648. DOI: 10.1186/s12885-024-13033-8.
Goncalves E, Fontes F, Rodrigues J, Calisto R, Bento M, Lunet N Breast Cancer Res Treat. 2024; 207(2):323-330.
PMID: 38869665 PMC: 11297125. DOI: 10.1007/s10549-024-07361-3.